GERGEN MARK J (President and CBO) received a stock award from POSEIDA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/1/2022ACC: 0001209191-22-006171
DirectorOfficer· President and CBO
Since Jul 2020
+875.70K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
875.70K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+357.20K
Price / share
—
Trade value
—
% of position
New position
2/1/2022
0.00→357.20K
Total
Net shares
+357.20K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/1/2022 | A · Award | +357.20K | — | — | New position | 0.00 | 357.20K |
| Total | +357.20K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
518.50K shares
Shares
+518.50K
Strike price
4.75
Held after
518.50K
Exercisable
—
2/1/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock518.50K shares | 2/1/2022 | A · Award | +518.50K | 4.75 | — | 518.50K |